Aggregated data are provided in the paper tables. Individual level fertility data are available for Kisesa (Magu) and uMkhanyakude (Africa Centre) on the INDEPTH data repository <http://www.indepth-ishare.org/index.php/home>. Other data are not publicly available due to ethical restrictions but requests can be made to the individual study sites: TAZAMA cohort study <urassamark@yahoo.co.uk>, the Africa Centre <info@africacentre.ac.za>, MRC Uganda <mrc@mrcuganda.org> and UVRI <directoruvri@uvri.go.ug>.

Background {#sec005}
==========

There has been a rapid scale up in the provision of Antiretroviral therapy (ART) in Sub Saharan Africa in the last decade with more than 7.5 million people receiving treatment by the end of 2012\[[@pone.0151877.ref001]\] this comes hand in hand with increased access to HIV testing and therefore knowledge of HIV status. A large proportion of those with HIV in sub Saharan Africa are women of reproductive age who are routinely tested for HIV at antenatal care clinics (ANC) in order to try to prevent mother to child transmission and those testing positive are referred to clinics for treatment \[[@pone.0151877.ref002]\].

Official estimates of national HIV prevalence by UNAIDS are currently based on trends observed in antenatal clinic surveillance\[[@pone.0151877.ref003]\] and far more ANC data are becoming available due to routine reports from PMTCT programs. ANC prevalence trends are then adjusted to match prevalence levels estimated from national population surveys \[[@pone.0151877.ref004]\]. Part of this adjustment accounts for the reduced fertility of HIV positive women \[[@pone.0151877.ref005], [@pone.0151877.ref006]\], however increased access to care and treatment services and uptake of antiretroviral therapy may impact on the fertility of HIV positive women for biological and behavioural reasons, implying a need to re-estimate the adjustment factors used in these calculations.

There have been no longitudinal studies in Sub-Saharan Africa that have looked at the population level impact of ART on fertility. A few studies have measured fertility or incidence of pregnancy in women on ART \[[@pone.0151877.ref007]--[@pone.0151877.ref010]\] but these lack suitable comparators (HIV negative women in the same community) and may not be representative of all HIV positive women. A cross sectional comparison using Malawian Demographic and Health Survey data (DHS) found an increased probability of giving birth for HIV positive women relative to HIV negative women between 2004 and 2010 \[[@pone.0151877.ref011]\] which is attributed to the increase in access to mother to child transmission and ART services in Malawi. We analyse the effect of antiretroviral therapy provision on population-level fertility in four cohort studies in Southern and East Africa, comparing trends in HIV infected women against the secular trends observed in uninfected women.

Methods {#sec006}
=======

Sites and setting {#sec007}
-----------------

Fertility data that span the pre-ART era and the time of introduction and widespread use of ART are available from four community-based demographic and HIV surveillance sites: Kisesa (managed by the National Institute of Medical Research Mwanza in Northern Tanzania), Masaka (MRC/UVRI Uganda Research Unit on AIDS), Rakai (Rakai Health Sciences)--both in South-west Uganda, and uMkhanyukude (Africa Centre, in KwaZulu-Natal, South Africa). These sites belong to the network for analysing longitudinal population based data on HIV in Africa (ALPHA)\[[@pone.0151877.ref012], [@pone.0151877.ref013]\] and have been described in detail elsewhere \[[@pone.0151877.ref014]--[@pone.0151877.ref020]\].

Data, HIV and ART provision {#sec008}
---------------------------

The ALPHA network standardises site-specific data to a common format to enable joint analysis. In brief, each study records demographic data including dates of birth (of mothers and infants). The studies also collect data on HIV status and provide dates of testing and test results for their populations. In Kisesa, Rakai, and uMkhanyakude, the HIV surveys were done separately to the demographic surveillance rounds, and data were linked afterwards using unique identifiers. In Masaka, HIV testing was done immediately after demographic surveillance rounds which were used to list those eligible for HIV testing. HIV testing took place in the home for all sites apart from Kisesa where temporary village clinics are used to which people are transported from their homes. Prior to the availability of antiretroviral therapy, testing protocols used informed consent without disclosure, so that participants did not learn the results of the HIV research tests, however with the advent of ART, sites began to offer full pre-test and post-test counselling to the participants during the data collection round. Participants are still not obliged take part in the counselling or to learn their results. In Rakai the samples taken in the home were tested at the field laboratory and then returned by a community based counsellor to those participants requesting the results.

The introduction and level of uptake of ART in the different studies varies. ART was introduced in the study areas between 2004 and 2005, when selected clinics were allowed to administer drugs and people were mobilised to make them aware of the new services. Further details of ART introduction and uptake are described elsewhere\[[@pone.0151877.ref021]--[@pone.0151877.ref024]\].

Study Population {#sec009}
----------------

The population included in this analysis is women of reproductive age (15--44) living in the surveillance areas between the time point corresponding to five years before ART was introduced, to the last date for which data were available for each site up to 2015. [Table 1](#pone.0151877.t001){ref-type="table"} shows prevalence for each site in pre and post ART years for women aged 15--49.

10.1371/journal.pone.0151877.t001

###### HIV prevalence of women aged 15--49 in Study sites.

![](pone.0151877.t001){#pone.0151877.t001g}

  Study Site, Round (years)     ART period   N      Prevalence   (95% CI)
  ----------------------------- ------------ ------ ------------ ----------------
  Kisesa 4 (2003--2004)         Pre ART      3369   5.11         (4.36--5.85)
  Kisesa 6 (2010--2010)         Post ART     2445   7.08         (6.06--8.09)
  Manicaland 3 (2003--2005)     Pre ART      8273   20.45        (19.58--21.32)
  Manicaland 5 (2009--2011)     Post ART     6150   17.54        (16.59--18.50)
  Masaka 14 (2002--2003)        Pre ART      2361   14.06        (12.66--15.46)
  Masaka 16 (2004--2005)        Post ART     2485   17.99        (16.48--19.50)
  Rakai 9 (2002--2003)          Pre ART      3708   13.65        (12.54--14.75)
  Rakai 12 (2006--2008)         Post ART     4507   14.98        (13.93--16.02)
  uMkhanyakude 1 (2002--2005)   Pre ART      6533   27.2         (26.12--28.28)
  uMkhanyakude 4 (2007--2008)   Post ART     3604   27.58        (26.12--29.04)

All live births to women aged 15--44 years old while under observation in the study were included in the analysis, classified by mother's age, area of residence and HIV status at time of the birth, and by ART availability in the community. We did not include 45--49 year olds to create the standard fertility analysis grouping of 15--49 years as there were very few births to HIV positive women at this age.

All sites are predominately rural, though most contain areas with local markets, health and education facilities. Area of residence is classified differently for each site. The Masaka DSS is divided into two areas: old villages where surveillance began in 1989; and new villages where surveillance began in November 1999. In Kisesa sub-villages are classified according to their distance from the small trading centre on the main road. In Rakai the peri urban group comprises trading towns, villages along secondary roads and fishing communities and the rural category are communities beyond those located along secondary roads. uMkhanyakude is predominantly rural but also includes an small town and peri-urban densely populated areas.

Measures {#sec010}
--------

HIV Status was classified as negative, positive and unknown. Negative person time was defined as the time between first testing negative and last testing negative, also included in negative time was a site specific time following the last negative test, this was allocated according to the HIV incidence rates in the sites, the cut off for post negative time was taken as the time at which the cumulated probability of becoming infected following the last test reached 5%. This cut-off point was five years in Kisesa, Masaka and Rakai and two years in uMkhanyakude. HIV positive time was all the person time after the first positive test. The sero conversion interval was calculated as the mid point between first positive and last negative test and positive and negative time was assigned accordingly. Interval censoring was invoked if the midpoint of the sero conversion interval was longer than the site specific post negative time--in that case only the post negative time was assigned to negative and one year pre positive time was assigned to positive, the remainder of the interval was designated unknown. The composition of the unknown group over time changes due to the different ways HIV positive and HIV negative time is allocated and is also affected by participation changes in testing \[[@pone.0151877.ref025], [@pone.0151877.ref026]\] therefore we do not present results from this group. No pressure was put on participants to receive their HIV status as part of research survey procedures, therefore we would not expect a link between participation in testing and fertility.

Calendar time period of data availability relative to ART introduction varied across the sites ([Fig 1](#pone.0151877.g001){ref-type="fig"}), from 5 years prior to ART roll-out, to 9 years after. Calendar time was classified according to ART availability, grouped into pre ART, ART Introduction (introduced in at least one of the health facilities serving the community) and ART available (available in all the health facilities serving the community that were designated as ART providers according to national guidelines). We limit results presented for the short ART roll out period to just the age specific rates, as this time period is relatively short and is different in each site depending on the speed and nature of the roll out therefore tells us little about general patterns and trends.

![Dates of ART Periods included in the analysis.](pone.0151877.g001){#pone.0151877.g001}

Analysis {#sec011}
--------

We used Poisson regression to calculate age adjusted fertility rate ratios over time by HIV status, and investigated the interaction between ART period and HIV status to ascertain whether trends over time were different for HIV positive and negative women. We adjust for age and area of residence in this analysis to control for any changes in the composition of the study site that may have occurred between the pre and post ART periods. The analysis was performed separately for each site and pooled across sites where appropriate, the pooled results were adjusted by study site.

At ages under 20 HIV infection and fertility are highly correlated as many teenagers will not yet have had sex, and only those who have had sex are at risk of becoming pregnant or acquiring HIV. Therefore fertility in the 15--19 year old age group is almost always higher in HIV positive women \[[@pone.0151877.ref006]\]. We therefore stratify our analysis to look at 15--19 year olds and 20--44 year olds separately.

Ethics statements {#sec012}
-----------------

Each of the six sites contributing data to the pooled analysis has received ethical clearance from the appropriate local ethics review bodies, and from the corresponding Institutional Review Boards for studies which had collaborating partnerships with Northern Universities.

### uMkhanyakude {#sec013}

Annually re-certified ethics permission for the Africa Centre DSS and nested individual HIV surveillance among consenting adults is obtained from the Biomedical Research Ethics Committee at the Nelson Mandela School of Medicine, University of KwaZulu-Natal. Detailed written informed consent obtained for participation in the HIV surveillance.

### Kisesa {#sec014}

Ethical approval for each survey round of the Kisesa cohort study granted by the Tanzanian Medical Research Coordinating Committee and the Ethics Committee of the London School of Hygiene and Tropical Medicine. Prior to 2006, verbal consent was obtained directly from all study participants (aged 15 and over), due to low literacy rates among the study population. Consent was witnessed and documented for each study participant by a member of the sero-survey team or senior person from the community. From 2006 onward, consent was again obtained directly from all study participants, however a written consent option was introduced, for those able to provide this and written parental consent for those under 18 years was also obtained.

### Masaka {#sec015}

The MRC DSS is approved by the Uganda Virus Research Institute (UVRI) Science and Ethics Committee (SEC) and the Uganda National Council of Science and Technology (UNCST). Study participants provided written consent to participate in all parts of the study.

### Rakai {#sec016}

The Rakai Community Cohort Survey is approved by the UVRI SEC and UNCST. Literate participants provided written consent while those unable to read or write had a witness sign on their behalf. Those unable to read or write used a thumbprint to document consent and a witness would also sign as evidence that the consent had been read to the participant who had understood and consented to participate.

Results {#sec017}
=======

Overall crude and age specific fertility rates fell or remained the same between the pre and post ART periods for all sites (Tables [2](#pone.0151877.t002){ref-type="table"}--[5](#pone.0151877.t005){ref-type="table"}). Classifying the crude fertility rates by HIV status shows that overall fertility declined in the HIV negative but remained more or less the same or increased slightly for the HIV positive (For the HIV positive in Rakai this is true if we exclude 15--19 year olds). Age specific rates by HIV status follow this general trend for all sites apart from slight increases in HIV negative 25--34 year olds in Masaka, 35--39 year olds in Rakai and 15--19 year olds in uMkhanyakude. Overall fertility is higher in the rural areas for all sites.

10.1371/journal.pone.0151877.t002

###### Fertility of women aged 15--44 years old, by calendar time period and stratified by individual HIV status for Kisesa.
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                                     All    HIV-Negative   HIV-Positive                                     
  ---------------------------------- ------ -------------- -------------- ------ ------ ------- ----- ----- -------
  **Kisesa**                                                                                                
  **    ART Period**                                                                                        
  **            **Pre ART            5253   26.2           200.1          4108   17.6   233.1   132   1.0   126.9
  **            **ART Introduction   3715   19.5           190.6          2763   12.6   218.4   106   0.8   132.0
  **            **ART available      5895   37.2           158.3          2924   15.4   190.3   195   1.4   144.2
  **    Age**                                                                                               
  **        ***15--19*                                                                                      
  **            **Pre ART            846    6.2            136.6          584    3.6    160.2   12    0.1   197.6
  **            **ART Introduction   518    4.8            108.3          308    2.9    107.3   8     0.0   232.3
  **            **ART available      792    9.5            83.6           335    3.6    93.3    4     0.0   81.5
  **        ***20--24*                                                                                      
  **            **Pre ART            1461   5.4            270.8          1117   3.4    325.8   23    0.2   144.7
  **            **ART Introduction   952    3.8            250.7          714    2.3    309.2   9     0.1   97.5
  **            **ART available      1475   7.2            205.1          637    2.7    237.1   24    0.1   193.6
  **        ***25--29*                                                                                      
  **            **Pre ART            1294   4.9            264.1          1002   3.2    311.7   44    0.3   157.6
  **            **ART Introduction   897    3.3            270.1          676    2.1    315.3   34    0.2   202.7
  **            **ART available      1402   6.3            223.9          693    2.4    285.1   40    0.2   185.5
  **        ***30--34*                                                                                      
  **            **Pre ART            877    4.0            221.3          705    2.8    254.3   38    0.3   143.7
  **            **ART Introduction   746    3.1            237.7          563    2.1    272.0   32    0.2   133.3
  **            **ART available      1131   5.6            200.5          621    2.4    254.7   66    0.3   197.1
  **        ***35--39*                                                                                      
  **            **Pre ART            569    3.3            173.6          510    2.6    198.8   13    0.2   80.4
  **            **ART Introduction   426    2.4            180.9          356    1.7    212.8   16    0.2   102.2
  **            **ART available      805    5.0            162.5          454    2.3    201.2   55    0.4   131.9
  **        ***40--44*                                                                                      
  **            **Pre ART            206    2.5            81.8           190    2.0    95.0    2     0.1   17.3
  **            **ART Introduction   176    2.1            83.9           146    1.6    92.3    7     0.1   62.6
  **            **ART available      290    3.7            78.1           184    2.0    93.7    6     0.2   28.3
  **    Residence**                                                                                         
  **        ***Rural*                                                                                       
  **            **Pre ART            3125   13.4           233.2          2564   10.1   254.2   71    0.4   171.0
  **            **ART Introduction   2295   9.9            232.0          1805   7.2    252.4   54    0.3   162.7
  **            **ART available      3453   17.9           193.0          1932   8.9    215.9   103   0.6   164.3
  **        ***Peri Urban/Urban*                                                                            
  **            **Pre ART            2128   12.8           165.7          1544   7.5    204.8   61    0.6   97.6
  **            **ART Introduction   1420   9.6            147.9          958    5.5    174.2   52    0.5   110.4
  **            **ART available      2442   19.3           126.3          992    6.4    154.6   92    0.7   126.8

10.1371/journal.pone.0151877.t003

###### Fertility of women aged 15--44 years old, by calendar time period and stratified by individual HIV status for Masaka.

![](pone.0151877.t003){#pone.0151877.t003g}

                                          All    HIV-Negative   HIV-Positive                                     
  --------------------------------------- ------ -------------- -------------- ------ ------ ------- ----- ----- -------
  **Masaka**                                                                                                     
  **    ART Period**                                                                                             
  **            **Pre ART                 2524   14.8           170.1          2285   12.8   179.2   117   1.0   115.2
  **            **ART Introduction        510    3.3            153.6          466    2.8    164.0   21    0.3   83.8
  **            **ART available           4185   28.0           149.7          3672   23.3   157.4   281   2.3   119.7
  **    Age**                                                                                                    
  **        ***15--19*                                                                                           
  **            **Pre ART                 490    4.6            107.0          448    4.2    106.9   14    0.1   205.3
  **            **ART Introduction        101    1.0            105.3          91     0.9    102.3   2     0.0   112.2
  **            **ART available           665    8.5            78.5           593    7.6    77.6    25    0.2   159.4
  **        ***20--24*                                                                                           
  **            **Pre ART                 766    2.9            261.3          701    2.5    277.6   32    0.2   185.3
  **            **ART Introduction        155    0.6            245.1          145    0.5    266.8   3     0.0   77.3
  **            **ART available           1115   4.9            226.6          1005   4.1    242.6   58    0.3   186.8
  **        ***25--29*                                                                                           
  **            **Pre ART                 562    2.4            231.9          497    2.0    252.0   38    0.3   136.5
  **            **ART Introduction        126    0.5            229.9          115    0.4    260.9   6     0.1   101.3
  **            **ART available           1012   4.3            237.1          884    3.5    256.1   71    0.4   163.7
  **        ***30--34*                                                                                           
  **            **Pre ART                 357    1.9            192.4          316    1.5    211.9   20    0.2   88.8
  **            **ART Introduction        69     0.4            154.4          63     0.4    175.6   4     0.1   69.3
  **            **ART available           786    4.0            195.3          680    3.2    215.4   71    0.5   133.5
  **        ***35--39*                                                                                           
  **            **Pre ART                 263    1.7            152.8          241    1.4    168.4   11    0.2   62.7
  **            **ART Introduction        38     0.4            98.4           32     0.3    100.4   5     0.0   117.7
  **            **ART available           466    3.3            139.6          387    2.6    149.6   47    0.5   92.1
  **        ***40--44*                                                                                           
  **            **Pre ART                 86     1.3            64.9           82     1.1    71.7    2     0.1   20.9
  **            **ART Introduction        21     0.3            60.4           20     0.3    68.9    1     0.0   29.0
  **            **ART available           141    2.9            48.1           123    2.3    52.6    9     0.4   22.2
  **    Residence**                                                                                              
  **        ***Original Study Villages*                                                                          
  **            **Pre ART                 1989   11.3           175.5          1820   9.9    183.6   81    0.7   116.5
  **            **ART Introduction        382    2.4            158.1          347    2.1    164.8   16    0.2   97.8
  **            **ART available           3003   19.5           153.7          2675   16.6   161.4   182   1.5   121.4
  **        ***New villages*                                                                                     
  **            **Pre ART                 535    3.5            152.7          465    2.8    163.8   36    0.3   112.4
  **            **ART Introduction        128    0.9            141.6          119    0.7    161.6   5     0.1   57.4
  **            **ART available           1182   8.4            140.5          997    6.8    147.6   99    0.8   116.7

10.1371/journal.pone.0151877.t004

###### Fertility of women aged 15--44 years old, by calendar time period and stratified by individual HIV status for Rakai.
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                                     All    HIV-Negative   HIV-Positive                                     
  ---------------------------------- ------ -------------- -------------- ------ ------ ------- ----- ----- -------
  **Rakai**                                                                                                 
  **    ART Period**                                                                                        
  **            **Pre ART            6598   51.8           127.3          5805   35.9   161.8   495   5.5   90.2
  **            **ART Introduction   2598   23.1           112.5          2304   15.5   148.5   201   2.3   88.6
  **            **ART available      6634   68.7           96.6           5736   42.8   134.0   547   6.9   79.3
  **    Age**                                                                                               
  **        ***15--19*                                                                                      
  **            **Pre ART            1220   13.4           91.3           1119   8.1    137.3   38    0.3   131.0
  **            **ART Introduction   310    5.7            54.8           273    3.0    90.7    7     0.1   83.9
  **            **ART available      674    17.4           38.8           601    9.2    65.2    17    0.2   90.8
  **        ***20--24*                                                                                      
  **            **Pre ART            2320   12.8           181.4          2090   9.6    217.9   137   1.1   127.4
  **            **ART Introduction   872    5.4            161.6          799    3.8    208.7   50    0.4   129.5
  **            **ART available      1953   14.8           131.8          1651   9.0    183.0   125   0.9   139.0
  **        ***25--29*                                                                                      
  **            **Pre ART            1713   10.3           166.7          1460   7.3    199.5   183   1.6   116.7
  **            **ART Introduction   791    4.8            165.2          693    3.5    199.0   80    0.6   133.4
  **            **ART available      1992   13.7           145.9          1641   8.6    190.0   178   1.6   112.6
  **        ***30--34*                                                                                      
  **            **Pre ART            830    6.4            128.8          684    4.4    156.5   96    1.3   74.6
  **            **ART Introduction   425    3.4            124.9          369    2.4    155.8   40    0.6   65.0
  **            **ART available      1309   10.9           119.7          1077   6.8    158.5   131   1.7   75.4
  **        ***35--39*                                                                                      
  **            **Pre ART            382    4.8            79.0           331    3.4    96.4    36    0.8   45.4
  **            **ART Introduction   155    2.0            76.0           130    1.5    88.9    19    0.3   55.1
  **            **ART available      572    7.1            80.3           458    4.3    106.1   65    1.3   50.8
  **        ***40--44*                                                                                      
  **            **Pre ART            133    4.1            32.4           121    3.0    40.2    5     0.5   10.5
  **            **ART Introduction   45     1.8            24.9           40     1.4    29.3    5     0.2   21.0
  **            **ART available      134    4.8            28.1           116    2.9    40.3    7     0.8   8.4
  **    Residence**                                                                                         
  **        ***Rural*                                                                                       
  **            **Pre ART            5483   41.2           133.2          4872   29.3   166.4   390   4.2   91.9
  **            **ART Introduction   2200   18.2           121.1          1979   12.6   157.3   157   1.7   91.7
  **            **ART available      5156   49.7           103.7          4459   31.7   140.8   400   4.7   85.9
  **        ***Peri Urban/Urban*                                                                            
  **            **Pre ART            1115   10.7           104.5          933    6.6    141.4   105   1.2   84.3
  **            **ART Introduction   398    4.9            80.7           325    2.9    110.7   44    0.6   79.1
  **            **ART available      1401   18.5           75.7           1019   8.9    114.7   118   1.8   65.1

10.1371/journal.pone.0151877.t005

###### Fertility of women aged 15--44 years old, by calendar time period and stratified by individual HIV status for uMkhanyakude.
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                                     All     HIV-Negative   HIV-Positive                                       
  ---------------------------------- ------- -------------- -------------- ------ ------ ------- ------ ------ -------
  **uMkhanyakude**                                                                                             
  **    ART Period**                                                                                           
  **            **Pre ART            3337    31.8           104.8          1550   14.0   110.7   297    3.0    98.3
  **            **ART Introduction   3899    33.7           115.7          1887   15.3   123.6   581    4.9    119.1
  **            **ART available      11601   119.5          97.0           4741   41.0   115.7   2264   23.7   95.4
  **    Age**                                                                                                  
  **        ***15--19*                                                                                         
  **            **Pre ART            794     9.3            85.2           485    5.9    82.6    45     0.4    120.7
  **            **ART Introduction   1019    9.8            104.2          664    6.4    103.4   85     0.4    196.8
  **            **ART available      2836    32.8           86.4           1639   17.3   94.5    217    1.4    159.3
  **        ***20--24*                                                                                         
  **            **Pre ART            1014    6.6            154.5          435    2.4    182.2   95     0.7    138.7
  **            **ART Introduction   1262    7.4            169.6          589    3.2    182.4   211    1.1    184.9
  **            **ART available      3749    25.2           149.0          1631   9.3    175.4   587    4.2    140.2
  **        ***25--29*                                                                                         
  **            **Pre ART            653     4.8            135.3          209    1.3    167.0   77     0.7    116.3
  **            **ART Introduction   689     4.9            139.5          228    1.3    170.4   133    1.0    129.4
  **            **ART available      2398    20.3           118.2          661    4.5    145.5   680    5.6    122.0
  **        ***30--34*                                                                                         
  **            **Pre ART            491     4.1            121.0          206    1.2    168.9   47     0.5    86.7
  **            **ART Introduction   505     4.2            119.5          184    1.2    158.3   95     0.9    103.1
  **            **ART available      1487    15.9           93.8           397    3.0    132.4   483    5.1    94.7
  **        ***35--39*                                                                                         
  **            **Pre ART            284     3.6            79.9           154    1.5    104.6   27     0.4    64.8
  **            **ART Introduction   301     3.7            80.6           148    1.4    106.0   43     0.8    57.0
  **            **ART available      880     13.5           65.2           305    3.1    99.0    240    4.2    56.8
  **        ***40--44*                                                                                         
  **            **Pre ART            101     3.5            28.7           61     1.8    34.0    6      0.3    17.4
  **            **ART Introduction   123     3.6            34.3           74     1.7    42.9    14     0.6    23.3
  **            **ART available      251     11.9           21.1           108    3.7    29.2    57     3.3    17.3
  **    Residence**                                                                                            
  **        ***Rural*                                                                                          
  **            **Pre ART            2069    18.9           109.8          1076   9.6    112.2   165    1.6    100.3
  **            **ART Introduction   2382    19.8           120.2          1288   10.3   124.9   335    2.7    123.9
  **            **ART available      6955    66.2           105.1          3220   26.8   120.4   1190   12.2   97.7
  **        ***Peri Urban/Urban*                                                                               
  **            **Pre ART            1192    12.2           97.5           452    4.2    107.1   126    1.3    95.0
  **            **ART Introduction   1387    12.6           110.0          548    4.6    118.9   234    2.0    114.8
  **            **ART available      4476    48.4           92.5           1486   13.7   108.3   1048   10.8   97.1

Fertility rates in HIV positive women are consistently lower than those of HIV negative women apart from the youngest age group of 15--19 years olds ([Fig 2](#pone.0151877.g002){ref-type="fig"}). For all sites apart from uMkhanyakude fertility rates in HIV positive women aged over 20 are around half those of the negatives in the pre ART period and 0.73 (95%CI 0.64--0.83) times the negative rates in uMkhanyakude. In the post ART period overall the differences between positive and negative are smaller, with rate ratios ranging from 0.57 (95%CI 0.52--0.62) in Rakai to 0.83 (95%CI 0.78--0.87) in uMkhanyakude. In both periods fertility differences between positive and negative women become greater as age increases.

![Unadjusted fertility rate ratios by age and ART period comparing positives to negatives.](pone.0151877.g002){#pone.0151877.g002}

For all women aged 15--44 years old, age and residence adjusted fertility rates declined significantly over time, driven by the significant decline in fertility among HIV negative women in all four studies ([Table 6](#pone.0151877.t006){ref-type="table"}). For HIV positive women in Kisesa and Masaka there is a fertility increase of borderline significance of 1.21(95%CI 0.99--1.49) and 1.16(95%CI 0.96--1.41) respectively, and no change in uMkhanyakude and Rakai. The interaction term between HIV Status and ART period was significant for all sites apart from uMkhanyakude showing that the changes in fertility over the two ART periods are significantly different for HIV positive and HIV negative women. Excluding 15--19 year olds ([Table 7](#pone.0151877.t007){ref-type="table"}) whose fertility rates are determined largely by patterns of sexual debut, yields an overall reduction in fertility in HIV negative women in all sites and increases among HIV positive women in Kisesa and Masaka with rate ratios of 1.29 (95%CI 1.04--1.59) and 1.21 (95%CI 0.99--1.47) respectively, and no change in uMkhanyakude and Rakai. In this narrower age range the interaction terms between HIV Status and ART period were significant for all sites apart from Rakai.

10.1371/journal.pone.0151877.t006

###### Fertility Rate Ratio (FRR) for 15--44 year olds comparing ART period with pre ART adjusted for by age and residence.

![](pone.0151877.t006){#pone.0151877.t006g}

                   ART Period      HIV Negative   HIV Positive   Interaction p-value[\*](#t006fn001){ref-type="table-fn"}                  
  ---------------- --------------- -------------- -------------- ---------------------------------------------------------- -------------- -------
  *Kisesa*                                                                                                                                 
                   Pre-ART         1                             1                                                                         
                   ART Available   0.84           (0.81--0.88)   1.21                                                       (0.99--1.49)   0.001
  *Masaka*                                                                                                                                 
                   Pre-ART         1                             1                                                                         
                   ART Available   0.90           (0.86--0.94)   1.16                                                       (0.96--1.41)   0.010
  *uMkhanyakude*                                                                                                                           
                   Pre-ART         1                             1                                                                         
                   ART Available   0.98           (0.93--1.03)   1.04                                                       (0.92--1.16)   0.363
  *Rakai*                                                                                                                                  
                   Pre-ART         1                             1                                                                         
                   ART Available   0.84           (0.81--0.86)   0.96                                                       (0.86--1.08)   0.020

\*Interaction between ART period and HIV status

10.1371/journal.pone.0151877.t007

###### Fertility Rate Ratio (FRR) for 20--44 year olds comparing ART period with pre ART adjusted for by age and residence.

![](pone.0151877.t007){#pone.0151877.t007g}

                   ART Period      HIV Negative   HIV Positive   Interaction p-value[\*](#t007fn001){ref-type="table-fn"}                  
  ---------------- --------------- -------------- -------------- ---------------------------------------------------------- -------------- -------
  *Kisesa*                                                                                                                                 
                   Pre-ART         1                             1                                                                         
                   ART Available   0.89           (0.86--0.93)   1.29                                                       (1.04--1.59)   0.001
  *Masaka*                                                                                                                                 
                   Pre-ART         1                             1.00                                                                      
                   ART Available   0.94           (0.90--0.99)   1.21                                                       (0.99--1.47)   0.016
  *uMkhanyakude*                                                                                                                           
                   Pre-ART         1                             1                                                                         
                   ART Available   0.90           (0.84--0.95)   1.04                                                       (0.92--1.17)   0.033
  *Rakai*                                                                                                                                  
                   Pre-ART         1                             1                                                                         
                   ART Available   0.93           (0.90--0.96)   1.00                                                       (0.89--1.12)   0.252

\*Interaction between ART period and HIV status

The data for 20--44 year olds were pooled for the comparison of the period when ART was available with the pre ART period, giving overall rate ratios of 0.9 (95%CI 0.89--0.92) for HIV negative women and 1.08 (95%CI 1.01--1.16) for HIV positive women adjusted for age, residence and study site, with a significant interaction (p\<0.001) between HIV status and ART period. Focussing on 15--19 year olds ([Table 8](#pone.0151877.t008){ref-type="table"}), there has been a significant reduction in fertility for HIV negative women in all sites apart from uMkhanyakude where the relative increase was 1.11 (95%CI 1.01--1.22). The confidence intervals for the rate ratios for the HIV positive are very large, so no real pattern can be determined.

10.1371/journal.pone.0151877.t008

###### Fertility Rate Ratio (FRR) for 15--19 year olds comparing ART period with pre ART adjusted for by age and residence.

![](pone.0151877.t008){#pone.0151877.t008g}

                   ART Period      HIV Negative   HIV Positive   Interaction p-value[\*](#t008fn001){ref-type="table-fn"}                  
  ---------------- --------------- -------------- -------------- ---------------------------------------------------------- -------------- -------
  *Kisesa*                                                                                                                                 
                   Pre-ART         1                             1                                                                         
                   ART Available   0.56           (0.49--0.64)   0.40                                                       (0.14--1.12)   0.524
  *Masaka*                                                                                                                                 
                   Pre-ART         1                             1                                                                         
                   ART Available   0.75           (0.67--0.85)   0.73                                                       (0.41--1.32)   0.936
  *uMkhanyakude*                                                                                                                           
                   Pre-ART         1                             1                                                                         
                   ART Available   1.11           (1.01--1.22)   1.32                                                       (0.97--1.79)   0.278
  *Rakai*                                                                                                                                  
                   Pre-ART         1                             1                                                                         
                   ART Available   0.49           (0.44--0.53)   0.66                                                       (0.38--1.13)   0.277

\*Interaction between ART period and HIV stat

For the two sites with data available (Kisesa and Masaka) in the 5--10 years prior to ART there was no evidence of any interaction between HIV status and period when comparing the periods 0--5 years and 5--10 years prior to ART (Not shown).

Person years with unknown HIV status were lowest in Masaka at 7.2% in the pre ART period and 8.2% in the post ART period, in Rakai they were 20.2% and 27.7%, Kisesa 28.9% and 52.0%, uMkhanyakude 46.5% and 38.3% respectively. The HIV status unknown category includes the unclassified post negative time intervals and time before the first HIV test.

Discussion {#sec018}
==========

This analysis uses community based cohort studies to look at the population impact of ART on fertility. We have shown that changes in fertility have been different in HIV positive women compared to the HIV negative over the pre and post ART Period---representing a discontinuity since the pre ART era. This would indicate that the introduction of ART is narrowing the gap in fertility rates between the HIV positive and negative. These results are similar to those found in the cross sectional study using the Malawi DHS \[[@pone.0151877.ref011]\] which showed a decrease over two surveys in the relative difference in fertility comparing the HIV positive and HIV negative at the time of the survey. Since our longitudinal data can accurately measure HIV status at the time of birth these results are a strong affirmation of the cross-sectional findings.

Fertility dynamics, HIV and changes due to ART are complex and can be both biological and behavioural. Earlier studies showed that HIV positive women with further disease progression have lower fertility than the uninfected and those more recently infected \[[@pone.0151877.ref009], [@pone.0151877.ref010], [@pone.0151877.ref027]\]. Women with HIV also have increased risk of spontaneous abortion and still birth \[[@pone.0151877.ref028]\] which lower their fertility. It is possible that the improved health of women on ART increases their fecundity although one study found an increase in still births for HIV positive women on ART compared to those not on ART\[[@pone.0151877.ref029]\].

Relationship dynamics may also change: studies from the pre ART era have shown an increased risk of widowhood and marital dissolution for HIV positive women and low rates of remarriage \[[@pone.0151877.ref030], [@pone.0151877.ref031]\], therefore decreasing their chances to bear more children. In the era of ART the risk of widowhood will decrease and marital dissolution rates may change leading to more opportunity for childbearing.

Fertility intentions are likely also to change, HIV positive women are more likely to report desiring fewer births than those uninfected\[[@pone.0151877.ref032]\] but some studies that compared fertility intentions of HIV positive women on treatment to those not on treatment found an increase in desire for children with increasing duration on ART \[[@pone.0151877.ref007], [@pone.0151877.ref008], [@pone.0151877.ref033]\]. It is unclear whether these intentions translate into actual increases in fertility. A cross sectional study from a perinatal HIV Research Unit in Soweto found no difference in fertility intentions between those on ART or not\[[@pone.0151877.ref034]\]--however all participants were attending the HIV clinic so according to the authors, the intentions of those not yet on treatment may have been shaped by the knowledge that ART was available when needed. A multicounty HIV care and treatment program cohort study in sub-Saharan Africa reported HIV positive women on treatment having 1.74(95%CI 1.19--2.54) higher incidence of pregnancy than those not on treatment\[[@pone.0151877.ref009]\]. The study was unable to determine the factors underlying the results with both biological and behavioural factors being possible.

This analysis shows the extent of changes in fertility trends at the population level which is important for modellers and policy makers. It does not tell us how much of the change is attributable to biological factors directly associated with improved health of those receiving ART, psychological changes that alter fertility intentions, or social changes in marital dynamics and stigma. It is important to note that in the pre ART era most people in these studies would not have known their HIV status so reasons for low fertility in the HIV positives would not include a conscious desire for fewer children motivated by knowledge of status. These topics need further analysis with individual linkage to clinic data to classify time on treatment, to investigate biological factors, and more detailed demographic and behavioural background characteristics.

Differences in fertility between HIV positive and HIV negative women are narrowing over time as ART becomes more widely available in these communities. Routine adjustment of ANC data for estimating national HIV prevalence will need to allow for the impact of treatment. Given the profound differences between fertility rate ratios and trends in infected and uninfected women under 20 with those aged 20 and over, it would be useful to classify ANC data on HIV prevalence by age, reporting separately on those under 20.
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